Company profile: eStudySite
1.1 - Company Overview
Company description
- Provider of clinical research services delivering study-related care and conducting inpatient and outpatient protocols, including first-in-human, pivotal, and post-marketing studies; specializing in infectious disease trials (antibiotics, antivirals, vaccines, diagnostics). Expertise in endocrinology, hepatology, dermatology, gastroenterology; infusion center; community recruitment; ICH/FDA/GCP-compliant, ACLS/BLS-certified staff.
Products and services
- Clinical Research Services: Architects in- and out-patient clinical protocols spanning first-in-human, pivotal trials, and post-marketing support under ICH-compliant processes with ACLS/BLS-certified staff
- Infectious Disease Trials: Engineers targeted studies for antibiotics, antivirals, vaccines, and diagnostics for diverse cohorts, conducted using FDA-guideline compliant methodologies
- Inpatient/Outpatient Infusion Center: Operates a multi-study-capable infusion facility enabling concurrent in-patient and out-patient research, staffed by ACLS-certified nurses and BLS-certified team members
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to eStudySite
BioBridges
HQ: United States
Website
- Description: Provider of flexible expertise, services, and technologies for life sciences companies from discovery through commercialization, offering clinical operations, data management, regulatory affairs, safety & pharmacovigilance, biostatistics, and medical affairs to support studies, compliance, safety, and post-approval lifecycle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioBridges company profile →
DiscoveryBioMed
HQ: United States
Website
- Description: Provider of life sciences and biotechnology focused on integrating human cell physiology with the drug discovery critical path, based in Birmingham, AL.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiscoveryBioMed company profile →
LakePharma
HQ: United States
Website
- Description: Provider of integrated biologics CRDMO services from discovery and engineering to development and GMP manufacturing. Offerings include antibody discovery and engineering, protein engineering and production, cell line development, phage and yeast display, hybridoma technologies, viral vector platforms (Baculovirus, AAV, Lentivirus), plasmid DNA services, and ISO 13485:2016 GMP manufacturing of mRNA, antibodies, proteins, and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LakePharma company profile →
BCI Pharma
HQ: France
Website
- Description: Provider of kinase inhibitor discovery and development solutions, including a proprietary platform to identify novel, potent and selective kinase inhibitors for various diseases; medicinal chemistry and biology laboratories for design, synthesis and cell-based assay development; a preclinical candidate for peripheral neuropathic pain and psoriasis; and risk-sharing collaborations on kinase research projects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BCI Pharma company profile →
Synteract HCR
HQ: United States
Website
- Description: Provider of global full-service contract research organization support for biotechnology, medical device, and pharmaceutical companies across all phases of clinical development, delivering customized Phase I–IV services collaboratively and cost effectively.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synteract HCR company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for eStudySite
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to eStudySite
2.2 - Growth funds investing in similar companies to eStudySite
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for eStudySite
4.2 - Public trading comparable groups for eStudySite
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →